WWW.BOOK.DISLIB.INFO
FREE ELECTRONIC LIBRARY - Books, dissertations, abstract
 
<< HOME
CONTACTS



Pages:     | 1 |   ...   | 31 | 32 || 34 |

«2013 Annual Report breakthrough technologies and services focused on Dear Fellow Shareholders, addressing specific customer and market needs. Several ...»

-- [ Page 33 ] --

Item 11. Executive Compensation The information required to be disclosed by this Item pursuant to Item 402 and Item 407(e) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the captions “Information Relating to Our Board of Directors and Its Committees—Director Compensation,” “—Compensation Committee Interlocks and Insider Participation,” and “Executive Compensation,” and is incorporated in this annual report on Form 10-K by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information required to be disclosed by this Item pursuant to Item 403 of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the caption “Beneficial Ownership of Common Stock,” and is incorporated in this annual report on Form 10-K by reference.

The information required to be disclosed by this Item pursuant to Item 201(d) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the caption “Executive Compensation—Equity Compensation Plan Information,” and is incorporated in this annual report on Form 10-K by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence The information required to be disclosed by this Item pursuant to Item 404 of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the caption “Information Relating to Our Board of Directors and Its Committees—Certain Relationships and Policies on Related Party Transactions,” and is incorporated in this annual report on Form 10-K by reference.

The information required to be disclosed by this Item pursuant to Item 407(a) of Regulation S-K is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the caption “Information Relating to Our Board of Directors and Its Committees—Determination of Independence,” and is incorporated in this annual report on Form 10-K by reference.

Item 14. Principal Accountant Fees and Services The information required to be disclosed by this Item pursuant to Item 9(e) of Schedule 14A is contained in the proxy statement for our annual meeting of stockholders to be held on April 22, 2014 under the caption “Information Relating to Our Board of Directors and Its Committees—Independent Registered Public Accounting Firm Fees and Other Matters”, and is incorporated in this annual report on Form 10-K by reference.

PART IV

Item 15.

Exhibits and Financial Statement Schedules

(a) DOCUMENTS FILED AS PART OF THIS REPORT:

1. FINANCIAL STATEMENTS

Included in Part II, Item 8:

Report of Independent Registered Public Accounting Firm Consolidated Statements of Operations for Each of the Three Fiscal Years in the Period Ended December 29, 2013 Consolidated Statements of Comprehensive Income for Each of the Three Fiscal Years in the Period Ended December 29, 2013 Consolidated Balance Sheets as of December 29, 2013 and December 30, 2012 Consolidated Statements of Stockholders’ Equity for Each of the Three Fiscal Years in the Period Ended December 29, 2013 Consolidated Statements of Cash Flows for Each of the Three Fiscal Years in the Period Ended December 29, 2013 Notes to Consolidated Financial Statements

2. FINANCIAL STATEMENT SCHEDULE

Schedule II—Valuation and Qualifying Accounts We have omitted financial statement schedules, other than those we note above, because of the absence of conditions under which they are required, or because the required information is given in the financial statements or notes thereto.

3. EXHIBITSExhibitNo. Exhibit Title

2.1(1) Agreement and Plan of Merger, dated September 7, 2011, by and among PerkinElmer, Inc., PerkinElmer Hopkinton Co. and Caliper Life Sciences, Inc., filed with the Commission on September 13, 2011 as Exhibit 2.1 to our current report on Form 8-K and herein incorporated by reference.

3.1 PerkinElmer, Inc.‘s Restated Articles of Organization, filed with the Commission on May 11, 2007 as Exhibit 3.1 to our quarterly report on Form 10-Q and herein incorporated by reference.

3.2 PerkinElmer, Inc.‘s Amended and Restated By-Laws, filed with the Commission on April 28, 2009 as Exhibit 3.1 to our current report on Form 8-K and herein incorporated by reference.

4.1 Specimen Certificate of PerkinElmer, Inc.‘s Common Stock, $1 par value, filed with the Commission on August 15, 2001 as Exhibit 4.1 to our quarterly report on Form 10-Q and herein incorporated by reference.

4.2 Indenture dated as of October 25, 2011 between PerkinElmer, Inc. and U.S. Bank National Association, filed with the Commission on October 27, 2011 as Exhibit 99.1 to our current report on Form 8-K and herein incorporated by reference.

4.3 Supplemental Indenture dated as of October 25, 2011 between PerkinElmer, Inc. and U.S. Bank National Association, filed with the Commission on October 27, 2011 as Exhibit 99.2 to our current report on Form 8-K and herein incorporated by reference.





Exhibit No. Exhibit Title

4.4 Second Supplemental Indenture dated as of December 22, 2011 between PerkinElmer, Inc. and U.S.

Bank National Association, filed with the Commission on February 28, 2012 as Exhibit 4.4 to our annual report on Form 10-K and herein incorporated by reference.

10.1 Credit Agreement, dated as of January 8, 2014, among PerkinElmer, Inc., Wallac Oy and PerkinElmer Health Sciences, Inc. as Borrowers, JPMorgan Chase Bank N.A. as Administrative Agent, Bank of America, N.A. and Barclays Bank PLC as Co-Syndication Agents, The Royal Bank of Scotland PLC, Citibank, N.A. and HSBC Bank USA, National Association as Co-Documentation Agents, J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Barclays Bank PLC as Joint Bookrunners and Joint Lead Arrangers, and the other Lenders Party hereto, filed with the Commission on January 10, 2014 as Exhibit 10.1 to our current report on Form 8-K and herein incorporated by reference.

10.2* Employment Contracts:

(1) Third Amended and Restated Employment Agreement between PerkinElmer, Inc. and Robert F.

Friel, dated as of December 16, 2008, filed with the Commission on February 26, 2009 as Exhibit 10.4(2) to our annual report on Form 10-K and herein incorporated by reference;

(2) Amended and Restated Employment Agreement between PerkinElmer, Inc. and Daniel R.

Marshak, dated as of December 15, 2008, filed with the Commission on February 26, 2009 as Exhibit 10.4(5) to our annual report on Form 10-K and herein incorporated by reference;

(3) Employment Agreement by and between Joel S. Goldberg and PerkinElmer, Inc. dated as of July 21, 2008, filed with the Commission on August 8, 2008 as Exhibit 10.1 to our quarterly report on Form 10-Q and herein incorporated by reference;

(4) Employment Agreement by and between Frank Anders Wilson and PerkinElmer, Inc. dated as of April 28, 2009, filed with the Commission on April 30, 2009 as Exhibit 10.1 to our current report on Form 8-K and herein incorporated by reference;

(5) Employment Agreement by and between PerkinElmer, Inc. and John R. Letcher dated as of February 1, 2010, filed with the Commission on March 1, 2010 as Exhibit 10.4(9) to our annual report on Form 10-K and herein incorporated by reference;

(6) Form of Amendment, entered into by and between PerkinElmer, Inc. and each of the following executive officers on the dates indicated below, filed with the Commission on March 1, 2011 as

Exhibit 10.4(7) to our annual report on Form 10-K and herein incorporated by reference:

Executive Officer Date Joel S. Goldberg December 3, 2010 John R. Letcher December 13, 2010 Daniel R. Marshak December 17, 2010 Frank Anders Wilson December 21, 2010 (7) Employment Agreement between James Corbett and PerkinElmer, Inc. dated as of February 1, 2012, filed with the Commission on May 8, 2012 as Exhibit 10.1 to our quarterly report on Form 10-Q and herein incorporated by reference.

(8) Employment Agreement between Maurice H. Tenney and PerkinElmer, Inc. dated as of February 1, 2012, filed with the Commission on May 8, 2012 as Exhibit 10.2 to our quarterly report on Form 10-Q and herein incorporated by reference.

(9) Employment Agreement between Jonathan DiVincenzo and PerkinElmer, Inc. dated as of December 2, 2013, attached hereto as Exhibit 10.2(9).

Exhibit No. Exhibit Title (10) Amended and Restated Employment Agreement between Andrew Okun and PerkinElmer, Inc.

dated as of January 1, 2014, attached hereto as Exhibit 10.2(10).

10.3* PerkinElmer, Inc.’s 2005 Incentive Plan, filed with the Commission on March 18, 2005 as Appendix A to our definitive proxy statement on Schedule 14A and herein incorporated by reference.

10.4* PerkinElmer, Inc.’s Amended and Restated 2001 Incentive Plan, filed with the Commission on November 13, 2006 as Exhibit 10.1 to our quarterly report on Form 10-Q and herein incorporated by reference.

10.5* PerkinElmer, Inc.’s 2009 Incentive Plan, filed with the Commission on March 20, 2009 as Appendix A to our definitive proxy statement on Schedule 14A and herein incorporated by reference.

10.6* PerkinElmer, Inc.’s 2008 Deferred Compensation Plan, filed with the Commission on December 12, 2008 as Exhibit 10.1 to our current report on Form 8-K and herein incorporated by reference.

10.7* First Amendment to PerkinElmer, Inc.’s 2008 Deferred Compensation Plan, filed with the Commission on March 1, 2011 as Exhibit 10.9 to our annual report on Form 10-K and herein incorporated by reference.

10.8* PerkinElmer, Inc.’s 2008 Supplemental Executive Retirement Plan, filed with the Commission on December 12, 2008 as Exhibit 10.2 to our current report on Form 8-K and herein incorporated by reference.

10.9* PerkinElmer, Inc.’s Performance Unit Program Description, filed with the Commission on February 6, 2009 as Exhibit 10.10 to our annual report on Form 10-K and herein incorporated by reference.

10.10* PerkinElmer, Inc.’s Performance Incentive Plan (Executive Officers), filed with the Commission on February 6, 2009 as Exhibit 10.11 to our annual report on Form 10-K and herein incorporated by reference.

10.11* PerkinElmer, Inc.’s Amended and Restated Life Sciences Incentive Plan, filed with the Commission on November 13, 2006 as Exhibit 10.2 to our quarterly report on Form 10-Q and herein incorporated by reference.

10.12* PerkinElmer, Inc. 1998 Employee Stock Purchase Plan as Amended and Restated on December 10, 2009, filed with the Commission on March 1, 2010 as Exhibit 10.15 to our annual report on Form 10-K and herein incorporated by reference.

10.13* Amendment to Vested Option Awards from PerkinElmer, Inc. to Robert F. Friel dated June 23, 2004, filed with the Commission on August 6, 2004 as Exhibit 10.4(b) to our quarterly report on Form 10-Q and herein incorporated by reference.

10.14* Form of Stock Option Agreement given by PerkinElmer, Inc. to its executive officers for use under the 2005 Incentive Plan, filed with the Commission on November 13, 2006 as Exhibit 10.3 to our quarterly report on Form 10-Q and herein incorporated by reference.

10.15* Form of Stock Option Agreement given by PerkinElmer, Inc. to its chairman and chief executive officer for use under the 2005 Incentive Plan, filed with the Commission on November 13, 2006 as Exhibit 10.4 to our quarterly report on Form 10-Q and herein incorporated by reference.

10.16* Form of Stock Option Agreement given by PerkinElmer, Inc. to its non-employee directors for use under the 2005 Incentive Plan, filed with the Commission on March 1, 2007 as Exhibit 10.23 to our annual report on Form 10-K and herein incorporated by reference.

ExhibitNo. Exhibit Title

10.17* PerkinElmer, Inc.’s Form of Restricted Stock Agreement with time-based vesting under the 2005 Incentive Plan, filed with the Commission on December 12, 2008 as Exhibit 10.3 to our current report on Form 8-K and herein incorporated by reference.



Pages:     | 1 |   ...   | 31 | 32 || 34 |


Similar works:

«Aus der Klinik für Rheumatologie und Klinische Immunologie der Medizinischen Fakultät der Charité Universitätsmedizin Berlin DISSERTATION Isolierung, Kultivierung und magnetische Separation von Vorläuferzellen aus humanem respiratorischem Epithel Zur Erlangung des akademischen Grades Doctor medicinae (Dr. med.) vorgelegt der Medizinischen Fakultät der Charité Universitätsmedizin Berlin von Marek Wentges aus Bonn Dekan: Prof. Dr. med. Martin Paul Gutachter: 1. PD Dr. Michael Sittinger,...»

«Pflegebedürftigkeitsfreie Lebenserwartung in Deutschland. Ein Beitrag zur Debatte um die Kompression von Morbidität Dissertation zur Erlangung des Grades Doctor of Public Health (Dr. PH) der Fakultät für Gesundheitswissenschaften der Universität Bielefeld Vorgelegt von Dagmar Pattloch, M.A. Lütticher Str. 3 13353 Berlin Erstgutachter: Prof. Dr. Ralf E. Ulrich Zweitgutachter: Prof. Dr. Wolfgang Greiner Berlin, Juni 2010 Sein Schwert hängte er über den Kamin. und obgleich nur wenige...»

«Versuch 2.8-B: Grundlagen der Positronen-Emissions-Tomographie (PET) Die Positronen-Emissions-Tomographie ist ein in der Medizin verwendetes Verfahren zum Nachweis physiologischer Prozesse. Man untersucht dabei das ortsund zeitabhängige Verhalten radioaktiver Markierungsstoffe, die dem Patienten appliziert wurden. Dazu nutzt man die e+e– -Vernichtung aus, bei der zwei kollinare Photonen entstehen. Diese weist man dann in einem Detektorpaar gleichzeitig (koinzident) nach. Bei diesem Versuch...»

«GUIDANCE FOR APPLICANTS INFORMED CONSENT For the purposes of the Ethics Review process, the definition of Informed Consent given in the Directive 2001/20/EC relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use is adopted. The principle of informed and free decision remains valid for any other kind of research. Informed Consent is the decision, which must be written, dated and signed, to take part in a clinical trial,...»

«Tierärztliche Hochschule Hannover Verfütterung von unbehandelter und pasteurisierter Sperrmilch und Tankmilch an Aufzuchtkälber: Auswirkungen auf Gewichtsentwicklung, Tiergesundheit und antimikrobielle Resistenzmuster fäkaler Bakterien INAUGURAL – DISSERTATION zur Erlangung des Grades einer Doktorin der Veterinärmedizin Doctor medicinae veterinariae Dr. med. vet. ) vorgelegt von Vanessa Aust Bochum Hannover 2013 Wissenschaftliche Betreuung: Apl.-Prof. Dr. M. Kaske Klinik für Rinder...»

«Gauvin & Higgs FMNL3 cellular dynamics The formin FMNL3 assembles plasma membrane protrusions that participate in cell-cell adhesion Timothy J. Gauvin, Lorna E. Young & Henry N. Higgs* Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover NH *Address correspondence to henry.higgs@dartmouth.edu Running head: FMNL3 cellular dynamics FMNL3 is a vertebrate-specific formin protein that has previously been shown to play a role in angiogenesis and cell migration. Here, we define...»

«Aus dem Fachbereich Medizin der Johann Wolfgang Goethe-Universität Frankfurt am Main, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie (KAIS) Direktor: Prof. Dr. Dr. Kai Zacharowski, FRCA Kommunikationsund Patientenübergabemanagement in der Notfallmedizin Dissertation zur Erlangung des Doktorgrades der Medizin des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt am Main vorgelegt von Rainer Peter Waßmer aus Bühl Frankfurt am Main, 2009 Dekan: Prof. Dr....»

«Zeitschrift für Kritische Musikpädagogik (ZfKM) Herausgegeben von Jürgen Vogt In Verbindung mit Matthias Flämig, Anne Niessen, Christian Rolle Kontaktadresse: http://home.arcor.de/zf/zfkm/home.html Elektronischer Artikel Pio, Frederik: The Heritage of the Musicality Discourse. A Genealogy of the Medical Concept of Amusia http://home.arcor.de/zfkm/07-pio1.pdf © Frederik Pio, 2007, all rights reserved Frederik Pio   The Heritage of the Musicality Discourse: A Genealogy of the Medical...»

«TRUSTED IT SOLUTIONS FOR HEALTHCARE PROVIDERS BEST PRACTICES FOR HEALTHCARE PRIVACY AND SECURITY REQUIREMENTS EMC HEALTHCARE SOLUTIONS ABSTRACT Compliance with federal regulations governing privacy and security of health information is mandatory and yet, many healthcare organizations are far from meeting all requirements. This white paper presents the challenges imposed by evolving HIPAA and ARRA HITECH rules, along with best practices for addressing those requirements with trusted IT...»

«Hans-Peter Kröner Skript zum Teil „Medizingeschichte“ der GTE-Vorlesung 1. Konzepte der Medizin 1.1 Das magisch-animistische Konzept 1.2 Theurgische Medizin 1.3 Das Humoralpathologische Konzept 1.3.1 Exkurs: Der Eid des Hippokrates 1.3.2 Überlieferungswege der antiken Medizin 1.4 Exkurs: Renaissance und Medizin 1.5 Neue Konzepte: Iatrochemie, Iatrophysik, Iatrodynamik 1.6 Iatromorphologische Konzepte 1.7 Das naturwissenschaftliche Krankheitskonzept 2. Medizin und Nationalsozialismus 2.1...»





 
<<  HOME   |    CONTACTS
2016 www.book.dislib.info - Free e-library - Books, dissertations, abstract

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.